Lung Diseases Clinical Trial
— UL2DLROfficial title:
Concordance of Image Quality Between an Ultra-Low Dose (ULD) Scanner and Standard Dose Conventional Scanner for Thoraco-abdominopelvic Scans
The new image reconstruction algorithm (Precise Image, Philips Healthcare) has a strong potential to maintain sufficient image quality suitable for diagnosis with ultra-low dose (ULD) chest and abdomen-pelvis scans. The hypothesis is that the images obtained with the Precise Image algorithm for ULD acquisitions are of sufficient and suitable quality for the diagnosis of certain lung, abdominal-pelvic and bone lesions.
Status | Not yet recruiting |
Enrollment | 116 |
Est. completion date | March 1, 2024 |
Est. primary completion date | January 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient having given free and informed consent. - Patient who has signed the consent form. - Patient affiliated to or beneficiary of a health insurance plan. - Patient with a BMI < 35 kg/m2 Exclusion Criteria: - Patient participating in research involving human subjects defined as Category 1. - Patient in an exclusion period as determined by another study. - Patient under court protection, guardianship or trusteeship. - Patient unable to give consent. - Patient for whom it is impossible to give informed information. - Pregnant patient. - Patient with a BMI = 35 kg/m2 |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Concordance of the global quality of thoraco-abdomino-pelvic images from an Ultra-Low-Dose scanner acquisition compared to a standard dose scanner acquisition | A 4-point Likert scale will be used to evaluate the overall image quality to see whether it is good enough to visualize the structures of interest and possible lesions.
Overall image quality is rated as follows: Completely interpretable without noise, smoothing, and/or artifact, Completely interpretable with low artifacts and/or low level of noise or/and smoothing, Interpretable with moderate noise and/or smoothing and moderate artifacts, Uninterpretable |
Day 0 | |
Secondary | Distribution of image quality with the standard dose scanner | Distribution of image quality for each of the two examinations of interest (ULD scanner and standard dose scanner) and to estimate the frequency of good quality images (level 1-2) for each of the two examinations.
- Fully interpretable without noise, smoothing and/or artifact, - Fully interpretable with low artifacts and/or low noise and/or smoothing, - Interpretable despite moderate noise and/or smoothing and moderate artifacts, - Not interpretable |
Day 0 | |
Secondary | Frequency of good quality images with the standard dose scanner | Distribution of image quality for each of the two examinations of interest (ULD scanner and standard dose scanner) and to estimate the frequency of good quality images (level 1-2) for each of the two examinations. Grouping of the variable into 2 classes for the estimation of the frequency of good quality (1-2) images:- 1-2 vs. 3-4 | Day 0 | |
Secondary | Distribution of image quality with the Ultra-Low-Dose scanner | Distribution of image quality for each of the two examinations of interest (ULD scanner and standard dose scanner) and to estimate the frequency of good quality images (level 1-2) for each of the two examinations.
- Fully interpretable without noise, smoothing and/or artifact, - Fully interpretable with low artifacts and/or low noise and/or smoothing, - Interpretable despite moderate noise and/or smoothing and moderate artifacts, - Not interpretable |
Day 0 | |
Secondary | Frequency of good quality images with the Ultra-Low-Dose scanner | Distribution of image quality for each of the two examinations of interest (ULD scanner and standard dose scanner) and to estimate the frequency of good quality images (level 1-2) for each of the two examinations. Grouping of the variable into 2 classes for the estimation of the frequency of good quality (1-2) images:- 1-2 vs. 3-4 | Day 0 | |
Secondary | Confidence level of each radiologist's diagnosis : Ultra-Low-Dose scan acquisition | To compare the confidence level of each radiologist's diagnosis for each of the two examinations of interest (Ultra-Low-Dose scan and standard dose scan) a subjective assessment of the each radiologist's (Junior/Senior) diagnostic confidence level will be made. | Day 0 | |
Secondary | Confidence level of each radiologist's diagnosis : Standard-Dose scan acquisition | To compare the confidence level of each radiologist's diagnosis for each of the two examinations of interest (Ultra-Low-Dose scan and standard dose scan) a subjective assessment of the each radiologist's (Junior/Senior) diagnostic confidence level will be made. | Day 0 | |
Secondary | Inter-rater agreement (Senior vs. junior radiologist) regarding the Ultra-Low-Dose scan acquisitions | Likert scales for global image quality and the level of confidence of the diagnosis will be used to assess inter-rater agreement (senior radiologist vs. junior radiologist) for each CT acquisition. | Day 0 | |
Secondary | Inter-rater agreement (Senior vs. junior radiologist) regarding the Standard-Dose scan acquisitions | Likert scales for global image quality and the level of confidence of the diagnosis will be used to assess inter-rater agreement (senior radiologist vs. junior radiologist) for each CT acquisition. | Day 0 | |
Secondary | Overall concordance of the diagnosis. Thoracic lesions seen on the Ultra-Low-Dose scan | Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients.
Presence of at least one thoracic, (Yes/No) |
Day 0 | |
Secondary | Overall concordance of the diagnosis. Thoracic lesions seen on the Standard-Dose scan | Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one thoracic lesion (Yes/No) | Day 0 | |
Secondary | Overall concordance of the diagnosis. Abdominal lesions seen on the Ultra-Low-Dose scan | Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one abdominal lesion (Yes/No) | Day 0 | |
Secondary | Overall concordance of the diagnosis. Abdominal lesions seen on the Standard-Dose scan | Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one abdominal lesion (Yes/No) | Day 0 | |
Secondary | Overall concordance of the diagnosis. Pelvic lesions seen on the Ultra-Low-Dose scan | Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one pelvic lesion (Yes/No) | Day 0 | |
Secondary | Overall concordance of the diagnosis. Pelvic lesions seen on the Standard-Dose scan | Overall concordance of the diagnosis of thoracic, abdominal and/or pelvic lesions made from a ULD scan or from a conventional standard dose scan in these patients. Presence of at least one pelvic lesion (Yes/No) | Day 0 | |
Secondary | Overall concordance of the diagnosis. Spine lesions seen on the Ultra-Low-Dose scan | Overall concordance of the diagnosis of bone lesions of the spine and pelvis made from a ULD scan or from a standard dose CT scan in these patients. Presence of at least one bone lesion within the spine (Yes/No). | Day 0 | |
Secondary | Overall concordance of the diagnosis. Spine lesions seen on the Standard-Dose scan | Overall concordance of the diagnosis of bone lesions of the spine and pelvis made from a ULD scan or from a standard dose CT scan in these patients. Presence of at least one bone lesion within the spine (Yes/No). | Day 0 | |
Secondary | Overall concordance of the diagnosis. Pelvic bone lesions seen on the Ultra-Low-Dose scan | Overall concordance of the diagnosis of bone lesions of the spine and pelvis made from a ULD scan or from a standard dose CT scan in these patients. Presence of at least one bone lesion on the pelvis (Yes/No). | Day 0 | |
Secondary | Overall concordance of the diagnosis. Pelvic bone lesions seen on the Standard-Dose scan | Overall concordance of the diagnosis of bone lesions of the spine and pelvis made from a ULD scan or from a standard dose CT scan in these patients. Presence of at least one bone lesion on the pelvis (Yes/No). | Day 0 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04908397 -
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
|
Phase 1 | |
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT03682354 -
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Completed |
NCT02926768 -
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Completed |
NCT00281216 -
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
N/A | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Completed |
NCT00269256 -
Stress, Environment, and Genetics in Urban Children With Asthma
|
N/A | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Active, not recruiting |
NCT00115297 -
Montelukast for Early Life Wheezing
|
Phase 2/Phase 3 | |
Completed |
NCT00094276 -
Intervention for Improving Asthma Care for Minority Children in Head Start
|
N/A | |
Completed |
NCT00091767 -
Genetic Studies in Difficult to Treat Asthma: TENOR
|
N/A | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00069823 -
Study of Acid Reflux in Asthma
|
Phase 3 |